|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Autism Spectrum Disorders: Is Mesenchymal Stem Cell Personalized Therapy the Future?显示文摘 | Dario Siniscalco Anna Sapone Alessandra Cirillo Catia Giordano Sabatino Maione Nicola Antonucci Ken-ichi Isobe | 2012 | Journal of Biomedicine and Biotechnology2012，，： | 2 |
| 2 | Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice显示文摘 | Dario Siniscalco Catia Giordano Umberto Galderisi Livio Luongo Nicola Alessio Giovanni Bernardo Vito Novellis Francesco Rossi Sabatino Maione | 2010 | Cellular and Molecular Life Sciences2010，，4： | 2 |
| 3 | Immunohistochemical detection with quantum dots 显示文摘 | Akhtar RS Latham CB Siniscalco D | 2007 | Methods Mol Biol2007，374，： | 1 |
| 4 | Strategies for the International Protection of the Environment显示文摘 | | 1993 | Jouranl of Public Economics1993，，： | 1 |
| 5 | Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain显示文摘 | Siniscalco D Fuccio C Giordano C | 2007 | Pharmacol Res2007，55，2： | 1 |
| 6 | Apoptotic genes expression in the lumbar dorsal horn in a model neuropathic pain in rat显示文摘 | MAIONE S SINISCALCO D GALDERISI U | 2002 | Neuroreport2002，13，1： | 1 |
| 7 | Privatization around the world:New Evidence from Panel Data显示文摘 | SINISCALCO Domenico Bortolotti and Fantini | 2001 | CESifo Working Paper Series2001，，600： | 1 |
| 8 | Isolation and characterization of four type-1 ribosome-inactivating proteins, with polynucleotide:adenosine glycosidase activity, from leaves of Phytolacca dioica L.显示文摘 | Antimo Di Maro Paola Valbonesi Andrea Bolognesi Fiorenzo Stirpe Paolo De Luca Gesualdo Siniscalco Gigliano Luciano Gaudio Pasquale Delli Bovi Pasquale Ferranti Antonio Malorni Augusto Parente | 1999 | Planta1999，，1： | 1 |
| 9 | Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice 显示文摘 | Siniscalco D Giordano C Galderisi U | 2011 | Front Integr Neurosci2011，5，： | 1 |
| 10 | Stem cell therapy: the great promise in lung disease显示文摘 | Siniscalco D Sullo N Maione S | 2008 | Ther Adv Respir Dis2008，2，3： | 1 |
| 11 | Stem cell therapy: the great promise in lung disease 显示文摘 | Siniscalco D Sullo N Malone S | 2008 | Therapeutic Advances in Respiratory Disease2008，2，2： | 1 |
| 12 | Environmental policy reconsid ered:The role of technological innovation显示文摘 | Carraro C Siniscalco D | 1994 | European Economic Review1994，38，34： | 1 |
| 13 | Strategies for the international protection of the environment显示文摘 | Carraro C Siniscalco D | 1997 | Journal of Public Economics1997，52，2： | 1 |
| 14 | Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease显示文摘 | Bruno D’Agostino Nikol Sullo Dario Siniscalco Antonella De Angelis Francesco Rossi | 2010 | Expert Opinion on Biological Therapy2010，，5： | 1 |
| 15 | Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease显示文摘 | D'Agostino B Sullo N Siniscalco D | 2010 | Expert Opin Biol Ther2010，10，： | 1 |
| 16 | Long-lasting effect of human mesenchymal stem cell systemic administration on pain-like behaviors, ceIIuar, and biomolecular modifications in neuropathic mice显示文摘 | Siniscalco D Giodano C Galderisi U | 2011 | Front Integr Neurosci2011，5，1： | 1 |
| 17 | AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathie pain 显示文摘 | Costa B Siniscalco D Trovato AE | 2006 | Br J Pharmacol2006，148，： | 1 |
| 18 | WJSC 6^(th) Anniversary Special Issues(2):Mesenchymal stem cells Mesenchymal stem cells in treating autism:Novel insights显示文摘Autism spectrum disorders(ASDs)are complex neurodevelopmental disorders characterized by dysfunctions in social interactions,abnormal to absent verbal communication,restricted interests,and repetitive stereotypic verbal and non-verbal behaviors,influencing the ability to relate to and communicate.The core symptoms of ASDs concern the cognitive,emotional,and neurobehavioural domains.The prevalence of autism appears to be increasing at an alarming rate,yet there is a lack of effective and definitive pharmacological options.This has created an increased sense of urgency,and the need to identify novel therapies.Given the growing awareness of immune dysregulation in a significant portion of the autistic population,cell therapies have been proposed and applied to ASDs.In particular,mesenchymal stem cells(MSCs)possess the immunological properties which make them promising candidates in regenerative medicine.MSC therapy may be applicable to several diseases associated with inflammation and tissue damage,where subsequent regeneration and repair is necessary.MSCs could exert a positive effect in ASDs through the following mechanisms:stimulation of repair in the damaged tissue,e.g.,inflammatory bowel disease;synthesizing and releasing anti-inflammatory cytokines and survival-promoting growth factors;integrating into existing neural and synaptic network,and restoring plasticity.The paracrine mechanisms of MSCs show interesting potential in ASD treatment.Promising and impressive results have been reported from the few clinical studies published to date,although the exact mechanisms of action of MSCs in ASDs to restore functions are still largely unknown.The potential role of MSCs in mediating ASD recovery is discussed in light of the newest findings from recent clinical studies. | Dario Siniscalco James Jeffrey Bradstreet Nataliia Sych Nicola Antonucci | 2014 | World Journal of Stem Cells2014，6，2： | 1 |
| 19 | Role of reactive oxy- gen species and spinal cord apoptotic genes in the develop- ment of neuropathic pain显示文摘 | Siniscalco D Fuccio C Giordano C | 2007 | Pharmacol Res2007，55，2： | 1 |
| 20 | AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain 显示文摘 | Costa B Siniscalco D Trovato AE | 2006 | Br J Pharmacol2006，148，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员